Attached files
| file | filename |
|---|---|
| EX-10.5.1 - EXHIBIT 10.5.1 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx1051.htm |
| EX-10.2.1 - EXHIBIT 10.2.1 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx1021.htm |
| EX-10.3.1 - EXHIBIT 10.3.1 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx1031.htm |
| EX-31.2 - EXHIBIT 31.2 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx312.htm |
| EX-10.5.2 - EXHIBIT 10.5.2 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx1052.htm |
| EX-10.4.2 - EXHIBIT 10.4.2 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx1042.htm |
| EX-10.4.1 - EXHIBIT 10.4.1 - Impax Laboratories, LLC | ipxl-06x30x2016x10qaxexx1041.htm |
| 10-Q/A - 10-Q/A - Impax Laboratories, LLC | ipxl-06x30x2016x10qa.htm |
EXHIBIT 31.1
CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, J. Kevin Buchi, certify:
1. | I have reviewed this Amendment No. 1 to the Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2016 of Impax Laboratories, Inc.; and | ||
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. | ||
January 6, 2017 | By: | /s/ J. Kevin Buchi | |
J. Kevin Buchi | |||
Interim President and Chief Executive Officer | |||